Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin
Pankaj Puar(St. Michael's Hospital), Subodh Verma(St. Michael's Hospital), Andrew T. Yan(St. Michael's Hospital), C. David Mazer(St. Michael's Hospital), Hwee Teoh(St. Michael's Hospital), Arjun Pandey(University of Ottawa), Kim A. Connelly(St. Michael's Hospital), David A. Hess(Western University), Adrian Quan(St. Michael's Hospital), Raj Verma(Royal College of Surgeons in Ireland), Makoto Hibino(St. Michael's Hospital)
Cited by 8
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
New Markers of Inflammation and Endothelial Cell Activation
|Circulation|2003|733
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2024|693
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|687